Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Building on striking phase 2 data which showed mean body weight reductions of approximately 24% at the highest dose over 48 weeks retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, potentially offering a more powerful metabolic effect than existing treatments
2007;293:R112734
Fine-Needle Aspiration Biopsy : A sample of thyroid tissue is taken to analyze for cancer cells
Zepbound, Wegovy, and Saxenda are GLP-1 drugs that mimic a hormone that curbs peoples appetites, causing significant weight loss
US$ 20.94
US$ 24.72
US$ 27.77
US$ 25.58
US$ 28.53
US$ 21.15
US$ 23.68
US$ 25.20
